THE ROLE OF C1 ESTERASE INHIBITOR (C1INH) IN ADVERSE EVENTS RELATED TO IVIG (ADR) - THE BENEFIT OF 5% IVIG PRODUCT

Session Name

PS23 - COMPLEMENT AND NATURAL IMMUNITY

Session Type

PARALLEL SESSIONS

Date

30.05.2021, Sunday

Session Time

10:00 - 12:00

Room

HALL E

Lecture Time

10:40 - 11:00

Presenter

• Joseph Harper, United States of America

Session Icon